Manic-depressive (bipolar) illness is a serious psychiatric disorder with a strong genetic predisposition. The disorder is likely to be multifactorial and etiologically complex, and the causes of genetic susceptibility have been difficult to unveil. Lithium therapy is a widely used pharmacological treatment of manic-depressive illness, which both stabilizes the ongoing episodes and prevents relapses. A putative target of lithium treatment has been the inhibition of the myo-inositol monophosphatase (IMPase) enzyme, which dephosphorylates myo-inositol monophosphate in the phosphatidylinositol signaling system. Two genes encoding human IMPases have so far been isolated, namely myo-inositol monophosphatase 1 (IMPA1) on chromosome 8q21.13-21.3 and myo-inositol monophosphatase 2 (IMPA2) on chromosome 18p11.2. In the present study, we have scanned for DNA variants in the human IMPA1 and IMPA2 genes in a pilot sample of Norwegian manic-depressive patients, followed by examination of selected polymorphisms and haplotypes in a family-based bipolar sample of Palestinian Arab proband-parent trios. Intriguingly, two frequent single-nucleotide polymorphisms (À461C4T and À207T4C) in the IMPA2 promoter sequence and their corresponding haplotypes showed transmission disequilibrium in the Palestinian Arab trios. No association was found between the IMPA1 polymorphisms and bipolar disorder, neither with respect to disease susceptibility nor with variation in lithium treatment response. The association between manic-depressive illness and IMPA2 variants supports several reports on the linkage of bipolar disorder to chromosome 18p11.2, and sustains the possible role of IMPA2 as a susceptibility gene in bipolar disorder.
GPR88, coding for a G protein-coupled orphan receptor that is highly represented in the striatum, is a strong functional candidate gene for neuropsychiatric disorders and is located at 1p22-p21, a chromosomal region that we have previously linked to bipolar disorder (BD) in the Sardinian population. In order to ascertain the relevance of GPR88 as a risk factor for psychiatric diseases, we performed a genetic association analysis between GPR88 and BD in a sample of triads (patient and both parents) recruited in the Sardinian and the Palestinian population as well as between GPR88 and schizophrenia (SZ) in triads from the Xhosa population in South Africa. We found a positive association between GPR88 and BD in the Sardinian and Palestinian triads. Moreover, we found a positive association between GPR88 and SZ in triads from the Xhosa population in South Africa. When these results were corrected for multiple testing, the association between GPR88 and BD was maintained in the Palestinian population. Thus, these results suggest that GPR88 deserves consideration as a candidate gene for psychiatric diseases and requires to be further investigated in other populations.
The ongoing SARS-COV-2 pandemic has brought about unprecedented challenges to individuals, communities, and healthcare systems worldwide. As the world braces for a potential second wave of COVID-19 infections, the seasonal influenza season is also looming. This article explores the coping strategies that individuals and healthcare systems can adopt to manage both the SARS-COV-2 pandemic and seasonal influenza. The article highlights the importance of vaccination, social distancing measures, and personal protective equipment in preventing the spread of both viruses. Additionally, it discusses the need for mental health support for individuals who are struggling to cope with the stressors brought about by these pandemics. The article concludes by emphasizing that a coordinated effort between individuals, communities, and healthcare systems is crucial in mitigating the impact of these pandemics on public health.
The currently developing devastating pandemic of the coronavirus disease 2019 (COVID-19) has took over the global attention. Meanwhile, another virus with high potentiality to grow into a global pandemic has emerged in China, where human infections of the strain genotype 4 (G4) reassortant Eurasian avian-like (EA) H1N1 virus had been reported. However, fortunately human-to-human transmission was not detected yet but we need to keep an eye out for such potential scenario particularly that by the time we fully understand the virus transmission it might be too late to contain it and prevent a second global crisis. Health systems are collapsing under the current COVID-19 pandemic, nevertheless, we need to prepare for worst situation of having two pandemics side-by-side which would be a disastrous threatening the entire humanity. A better international commitment for collaboration, one health and early detection and response system need to be on place worldwide.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.